Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure
Sams, C.; Jones, K.; Galea, K.S.; MacCalman, L.; Cocker, J.; Teedon, P.; Cherrie, J.W.; Van Tongeren, M. Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure. Toxics 2016, 4, 10. https://doi.org/10.3390/toxics4020010
Sams C, Jones K, Galea KS, MacCalman L, Cocker J, Teedon P, Cherrie JW, Van Tongeren M. Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure. Toxics. 2016; 4(2):10. https://doi.org/10.3390/toxics4020010
Chicago/Turabian StyleSams, Craig, Kate Jones, Karen S. Galea, Laura MacCalman, John Cocker, Paul Teedon, John W. Cherrie, and Martie Van Tongeren. 2016. "Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure" Toxics 4, no. 2: 10. https://doi.org/10.3390/toxics4020010